Welcome from the Division Chief
Welcome to the website for the Division of Infectious Diseases & HIV Medicine at Case Western Reserve University. We are incredibly proud of our tradition and accomplishments in contributing to the advancement of treatment of infectious diseases locally, nationally and worldwide.
Our core mission is to heal, to teach and to discover. Facing the challenges of emerging and re-emerging infectious diseases at home and across the globe; we pride ourselves on delivering the highest quality of care for our patients, providing exceptional fellowship training to the next generation of Infectious Diseases physicians and continuing to make scientific breakthroughs through our world renowned research.
STERIS Grant 2013 Awardees
The Division of Infectious Diseases & HIV Medicine at Case Western Reserve University and University Hospitals Case Medical Center, with funds from STERIS Corporation, are providing seed money to faculty to foster research in emerging and healthcare-associated infections. Investigators in the basic science and clinical departments in the School of Medicine and Hospital System as well as in other departments throughout the University were awarded. Awardees are as follows:
- Christine McDonald, PhD - Department of Pathobiology - Enhancement of cutaneous antimicrobial defenses to target MRSA infection
- Pushpa Pandiyan, MSc, PhD - School of Dental Medicine - A mechanism of immunomodulation during Oropharyngeal candidiasis
- Daniel Popkin, MD, PhD; Nicole Steinmetz, PhD (Co-PI) - Dermatology | Pathology | Microbiology & Molecular Biology (Popkin); Biomedical Engineering | Radiology | Materials Science and Engineering (Steinmetz) - Purging persistent viral infection with nanoparticle "seek and protect" therapy of pAPC
- Roxana Rojas, PhD - Infectious Diseases & HIV Medicine - Host oxidoreductases as targets of TB drugs
- Marion Skalweit, MD, PhD - Infectious Diseases & HIV Medicine - Bulgecin A for Resistant Gram-negatives
ClinicalRM Awarded NIH Contract to Support the STI CTG Program
September 10, 2013, Hinckley, OH – Clinical Research Management, Inc. (ClinicalRM) – a full-service Contract Research Organization (CRO) providing services for basic and applied research, clinical trials, and regulatory support – announced today it was awarded a contract by the Department of Health and Human Services, National Institutes of Health, Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID). The intent of the award is to provide a broad spectrum of services for the design and conduct of Phase I-IV clinical trials and clinical studies focused on the screening, diagnosis, treatment, prevention, and control of Sexually Transmitted Infections within the Sexually Transmitted Infections Clinical Trials Group (STI CTG) Program. Read the article.
UHCMC and CWRU Announce Licensing Agreement for the Development of Diagnostic Tests for HIV Drug Resistance
Case Western Reserve University has signed an exclusive worldwide licensing agreement granting University Hospitals (UH) Case Medical Center rights to a series of diagnostic tests to determine drug resistance and co-receptor tropism in human immunodeficiency virus (HIV).
The phenotypic and genotypic HIV tests (or assays) were invented by Eric Arts, PhD, Professor of Medicine in the Division of Infectious Diseases, Department of Medicine at Case Western Reserve School of Medicine, and Miguel Quiñones-Mateu, PhD, Assistant Professor, Department of Pathology at the School of Medicine and Scientific Director at the University Hospitals Translational Laboratory (UHTL).
The HIV assays provide a platform of diagnostic tests used by physicians and researchers to monitor the success of anti-HIV treatment by determining drug resistance and the ability of the virus to infect different cells within the patient. The HIV assays also can be used by academic and corporate researchers to develop novel strategies to block HIV replication. Read more...